
Time-dependent cost comparison and health economic impact analysis of second-line interventions for transplant-ineligible patients with relapsed or refractory diffuse large B cell lymphoma
Kurte MS, Siefen AC, Jakobs F, Poos T, von Tresckow J, von Tresckow B, Reinhardt HC, Kron F